Complement Therapeutics Ltd Raises Eur 5 Million Seed Financing By Bgv And Forbion And Appoints Dr Rafiq Hasan As Ceo
Complement Therapeutics Ltd Raises Eur 5 Million Seed Financing By Bgv And Forbion And Appoints Dr Rafiq Hasan As Ceo
02/23/22, 3:00 AM
Location
Money raised
€5 million
Round Type
seed
Complement Therapeutics Ltd (CTx), a preclinical stage University of Manchester spinout, announced today the completion of its EUR 5 million seed financing round from BioGeneration Ventures (BGV) and Forbion, two leading European venture capital firms. BGV provided the initial seed-funding in early 2021 with both Forbion and BGV now investing additional seed financing.